Response to "UNCERTAINTY MANAGEMENT IN REGULATORY AND HEALTH TECHNOLOGY ASSESSMENT DECISION-MAKING ON DRUGS: GUIDANCE OF THE HTAi-DIA WORKING GROUP"

doi:10.1017/S026646232300260X

. 2023 Oct 12;39(1):e70.

doi: 10.1017/S026646232300260X.

Response to "UNCERTAINTY MANAGEMENT IN REGULATORY AND HEALTH TECHNOLOGY ASSESSMENT DECISION-MAKING ON DRUGS: GUIDANCE OF THE HTAi-DIA WORKING GROUP"

Sabine Elisabeth Grimm¹, Xavier G L V Pouwels², Bram L T Ramaekers¹, Ben Wijnen³, Janneke Grutters⁴, Manuela A Joore¹

Affiliations

¹ Department of Clinical Epidemiology and Medical Technology Assessment, Maastricht University Medical Centre and Maastricht Health Economics and Technology Assessment Centre, School for Public Health and Primary Care (CAPHRI), Maastricht, The Netherlands.
² Department of Health Technology and Services Research, University of Twente, Enschede, The Netherlands.
³ Trimbos-instituut, Utrecht, The Netherlands.
⁴ Department for Health Evidence, Radboud University Medical Centre, Nijmegen, The Netherlands.

PMID: 37822085
PMCID: PMC11570063
DOI: 10.1017/S026646232300260X

Response to "UNCERTAINTY MANAGEMENT IN REGULATORY AND HEALTH TECHNOLOGY ASSESSMENT DECISION-MAKING ON DRUGS: GUIDANCE OF THE HTAi-DIA WORKING GROUP"

Sabine Elisabeth Grimm et al. Int J Technol Assess Health Care. 2023.

. 2023 Oct 12;39(1):e70.

doi: 10.1017/S026646232300260X.

Authors

Sabine Elisabeth Grimm¹, Xavier G L V Pouwels², Bram L T Ramaekers¹, Ben Wijnen³, Janneke Grutters⁴, Manuela A Joore¹

Affiliations

¹ Department of Clinical Epidemiology and Medical Technology Assessment, Maastricht University Medical Centre and Maastricht Health Economics and Technology Assessment Centre, School for Public Health and Primary Care (CAPHRI), Maastricht, The Netherlands.
² Department of Health Technology and Services Research, University of Twente, Enschede, The Netherlands.
³ Trimbos-instituut, Utrecht, The Netherlands.
⁴ Department for Health Evidence, Radboud University Medical Centre, Nijmegen, The Netherlands.

PMID: 37822085
PMCID: PMC11570063
DOI: 10.1017/S026646232300260X

No abstract available

Keywords: health technology assessment; healthcare decision-making; healthcare policy; managed entry agreements; uncertainty.

PubMed Disclaimer

Conflict of interest statement

All authors of this letter are also authors of the article “Development and Validation of the TRansparent Uncertainty ASsessmenT (TRUST) Tool for Assessing Uncertainties in Health Economic Decision Models” (11) that is mentioned in this letter.

Cited by

Response to uncertainty management in regulatory and health technology assessment decision-making on drugs: guidance of the HTAi-DIA Working Group - author's reply.
Hogervorst MA, Vreman R, Heikkinen I, Oortwijn W. Hogervorst MA, et al. Int J Technol Assess Health Care. 2023 Dec 18;40(1):e1. doi: 10.1017/S0266462323002817. Int J Technol Assess Health Care. 2023. PMID: 38108142 Free PMC article. No abstract available.

References

1. Hogervorst MA, Vreman R, Heikkinen I, et al. Uncertainty management in regulatory and health technology assessment decision-making on drugs: Guidance of the HTAi-DIA Working Group. Int J Technol Assess Health Care. 2023;39:e40. - PMC - PubMed
1. Claxton K. Exploring uncertainty in cost-effectiveness analysis. Pharmacoeconomics. 2008;26:781–798. - PubMed
1. Grutters JP, van Asselt MB, Chalkidou K, Joore MA. Healthy decisions: Towards uncertainty tolerance in healthcare policy. Pharmacoeconomics. 2015;33:1–4. - PubMed
1. Bilcke J, Beutels P, Brisson M, Jit M. Accounting for methodological, structural, and parameter uncertainty in decision-analytic models: A practical guide. Med Decis Making. 2011;31:675–692. - PubMed
1. Briggs AH. Handling uncertainty in cost-effectiveness models. Pharmacoeconomics. 2000;17:479–500. - PubMed

MeSH terms

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Cambridge University Press
- PubMed Central
Research Materials
- NCI CPTC Antibody Characterization Program
Miscellaneous
- NCI CPTAC Assay Portal

[1] Hogervorst MA, Vreman R, Heikkinen I, et al. Uncertainty management in regulatory and health technology assessment decision-making on drugs: Guidance of the HTAi-DIA Working Group. Int J Technol Assess Health Care. 2023;39:e40. - PMC - PubMed

[2] Hogervorst MA, Vreman R, Heikkinen I, et al. Uncertainty management in regulatory and health technology assessment decision-making on drugs: Guidance of the HTAi-DIA Working Group. Int J Technol Assess Health Care. 2023;39:e40. - PMC - PubMed

[3] Claxton K. Exploring uncertainty in cost-effectiveness analysis. Pharmacoeconomics. 2008;26:781–798. - PubMed

[4] Claxton K. Exploring uncertainty in cost-effectiveness analysis. Pharmacoeconomics. 2008;26:781–798. - PubMed

[5] Grutters JP, van Asselt MB, Chalkidou K, Joore MA. Healthy decisions: Towards uncertainty tolerance in healthcare policy. Pharmacoeconomics. 2015;33:1–4. - PubMed

[6] Grutters JP, van Asselt MB, Chalkidou K, Joore MA. Healthy decisions: Towards uncertainty tolerance in healthcare policy. Pharmacoeconomics. 2015;33:1–4. - PubMed

[7] Bilcke J, Beutels P, Brisson M, Jit M. Accounting for methodological, structural, and parameter uncertainty in decision-analytic models: A practical guide. Med Decis Making. 2011;31:675–692. - PubMed

[8] Bilcke J, Beutels P, Brisson M, Jit M. Accounting for methodological, structural, and parameter uncertainty in decision-analytic models: A practical guide. Med Decis Making. 2011;31:675–692. - PubMed

[9] Briggs AH. Handling uncertainty in cost-effectiveness models. Pharmacoeconomics. 2000;17:479–500. - PubMed

[10] Briggs AH. Handling uncertainty in cost-effectiveness models. Pharmacoeconomics. 2000;17:479–500. - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Response to "UNCERTAINTY MANAGEMENT IN REGULATORY AND HEALTH TECHNOLOGY ASSESSMENT DECISION-MAKING ON DRUGS: GUIDANCE OF THE HTAi-DIA WORKING GROUP"

Affiliations

Response to "UNCERTAINTY MANAGEMENT IN REGULATORY AND HEALTH TECHNOLOGY ASSESSMENT DECISION-MAKING ON DRUGS: GUIDANCE OF THE HTAi-DIA WORKING GROUP"

Authors

Affiliations

Conflict of interest statement

Similar articles

Cited by

References

MeSH terms

LinkOut - more resources

Full Text Sources

Research Materials

Miscellaneous